BlackRock’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331M | Sell |
|
|||||
|
2025
Q1 | $307M | Sell |
|
|||||
|
2024
Q4 | $316M | Sell |
|
|||||
|
2024
Q3 | $300M | Buy |
|
|||||
|
2024
Q2 | $242M | Buy |
|
|||||
|
2024
Q1 | $210M | Sell |
|
|||||
|
2023
Q4 | $212M | Buy |
|
|||||
|
2023
Q3 | $170M | Sell |
|
|||||
|
2023
Q2 | $210M | Buy |
|
|||||
|
2023
Q1 | $209M | Buy |
|
|||||
|
2022
Q4 | $186M | Sell |
|
|||||
|
2022
Q3 | $230M | Sell |
|
|||||
|
2022
Q2 | $241M | Sell |
|
|||||
|
2022
Q1 | $307M | Sell |
|
|||||
|
2021
Q4 | $424M | Buy |
|
|||||
|
2021
Q3 | $381M | Buy |
|
|||||
|
2021
Q2 | $268M | Sell |
|
|||||
|
2021
Q1 | $324M | Buy |
|
|||||
|
2020
Q4 | $196M | Sell |
|
|||||
|
2020
Q3 | $204M | Buy |
|
|||||
|
2020
Q2 | $238M | Sell |
|
|||||
|
2020
Q1 | $161M | Sell |
|
|||||
|
2019
Q4 | $249M | Sell |
|
|||||
|
2019
Q3 | $245M | Sell |
|
|||||
|
2019
Q2 | $285M | Sell |
|
|||||
|
2019
Q1 | $344M | Sell |
|
|||||
|
2018
Q4 | $375M | Sell |
|
|||||
|
2018
Q3 | $919M | Buy |
|
|||||
|
2018
Q2 | $676M | Buy |
|
|||||
|
2018
Q1 | $498M | Buy |
|
|||||
|
2017
Q4 | $410M | Buy |
|
|||||
|
2017
Q3 | $401M | Buy |
|
|||||
|
2017
Q2 | $326M | Buy |
|
|||||
|
2017
Q1 | $277M | Buy |
|
|||||
|
2016
Q4 | $159K | Sell |
|
|||||
|
2016
Q3 | $197K | Sell |
|
|||||
|
2016
Q2 | $572K | Buy |
|
|||||
|
2016
Q1 | $147K | Buy |
|
|||||
|
2015
Q4 | $56K | Sell |
|
|||||
|
2015
Q3 | $59K | Sell |
|
|||||
|
2015
Q2 | $673K | Buy |
|
|||||
|
2015
Q1 | $52K | Sell |
|
|||||
|
2014
Q4 | $71K | Buy |
|
|||||
|
2014
Q3 | $26K | Hold |
|
|||||
|
2014
Q2 | $34K | Sell |
|
|||||
|
2014
Q1 | $43K | Buy |
|
|||||
|
2013
Q4 | $23K | Sell |
|
|||||
|
2013
Q3 | $20K | Hold |
|
|||||
|
2013
Q2 | $18K | Buy |
|